PAREXEL Launches New China Advisory Service

November 1, 2018

Applied Clinical Trials

PAREXEL, a provider of global biopharmaceutical services, has launched a new China Advisory Service to help global biopharmaceutical companies participate in China. Services include agency engagement and agreements, early development, clinical operations, and more.

Read the full release here.

Related Content:

News